Scribd
Upload
2K views2 pages

Captopril

This document summarizes information about the drug Captopril (trade names Acenorm, Capoten) including its generic and trade names, the patient's dose, therapeutic effects, mechanism of action, onset and duration, adverse effects, contraindications, nursing responsibilities, and sources. It provides details on administering Captopril orally to treat a female patient for hypertension, including monitoring for side effects and educating the patient.

Uploaded by

John Louie Escarda
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOC, PDF, TXT or read online on Scribd
2K views2 pages

Captopril

This document summarizes information about the drug Captopril (trade names Acenorm, Capoten) including its generic and trade names, the patient's dose, therapeutic effects, mechanism of action, onset and duration, adverse effects, contraindications, nursing responsibilities, and sources. It provides details on administering Captopril orally to treat a female patient for hypertension, including monitoring for side effects and educating the patient.

Uploaded by

John Louie Escarda
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOC, PDF, TXT or read online on Scribd
You are on page 1/ 2

NAME: DIAGNOSIS: DATE OF ADMISSION: DRUG DATA

GENERIC NAME: Captopril TRADE NAME: Acenorm, Capoten PATIENTS DOSE 25mg tab BID MINIMUM DOSE: 6.25mg PO OD MAXIMUM DOSE: 25mg PO TID CONTENT: captopril AVAILABILITY: Tablets: 12.5mg, 25mg, 50mg, 100mg ROUTE OF ADMINISTRATION: PO PREGNANCY RISK CATEGORY: C; D in 2nd and 3rd trimesters THERAPEUTIC : Antihypertensiv e

AGE: SEX: FEMALE MECHANISM OF ACTION


Inhibits ACE, preventing conversion of angiotensin I to angiotensin II, a present potent vasoconstrictor. Less angiotensin II decreases peripheral arterial resistance, decreasing aldosterone secretion, which reduces sodium and water retention and lowers blood pressure. ONSET: 15-60min PEAK: 60-90min DURATION: 6-12hrs DRUG HALF-LIFE: less than 2hrs PATIENTS ACTUAL INDICATION: Hypertension

HEIGHT: WEIGHT: ADVERSE EFFECTS


CNS: dizziness, fainting, headache, malaise, fatigue, fever CV: tachycardia, hypotension, angina pectoris GI: abdominal pain, anorexia, constipation, diarrhea, dry mouth, nausea, vomiting HEMA: leukopenia, agranulocytosis, thrombocytopenia , pancytopenia METABOLIC: hyperkalemia RESPI: dry, persistent, nonproductive cough, dyspnea SKIN: urticarial rash, pruritus, alopecia

CLASSIFICA TION
PHARMACOL OGIC: ACE inhibitor

INDICATIONS
GENERAL: Hypertension Diabetic Neuropathy Heart failure Left ventricle dysfunction after acute MI

CONTRAINDICATIONS
CONTRAINDICATION: Hypersensitivity to drug or other ACE inhibitors PRECAUTIONS: Use cautiously in pts with impaired renal function or serious autoimmune disease, especially systemic lupus erythematosus, and in those who have been exposed to other drugs that affect WBC counts or immune responses

NURSING RESPONSIBILITIES
BEFORE: Check for doctors order, medication sheet and medication ticket. Determine hypersensitivity reactions. Assess for renal impairment and autoimmune diseases. Take BP. Assess patients knowledge about therapy. Brief patient about the drug. DURING: Observe asepsis. Be alert for adverse reactions. Equipment should be available for any allergic reactions. Withhold if BP is 90/60 and less. Give 1 hour before meals. AFTER: Monitor vital signs and report for any deviation. Instruct pt to report any signs of discomfort experience after therapy. Advise pt to report s/sx of infection. Urge pt to promptly report swelling of the face, lips, or mouth, or difficulty breathing. Encourage for continuity of therapeutic regimen. Document SOURCE: LWW. Nursing Drug Handbook. 2008. p286-288

SOURCE: LWW. Nursing Drug Handbook. 2008. P 286-288

SOURCE: LWW. Nursing Drug Handbook. 2008. p286-288

SOURCE: LWW. Nursing Drug Handbook. 2008. p286-288

SOURCE: LWW. Nursing Drug Handbook. 2008. p286-288

SOURCE: LWW. Nursing Drug Handbook. 2008. p286288

SOURCE: LWW. Nursing Drug Handbook. 2008. p286-288

You might also like